The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
neocuproine inhibits the reaction [ATP7A protein mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL1 protein]]; neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]]; neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL7 protein]]; neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNG protein]]; neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of VEGFA protein]]
neocuproine inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein]
[Copper binds to neocuproine] which results in increased activity of CASP3 protein; bathocuproine sulfonate inhibits the reaction [[Copper binds to neocuproine] which results in increased activity of CASP3 protein] neocuproine results in increased activity of CASP3 protein neocuproine inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein]
neocuproine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]; neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]]
neocuproine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL7 protein]; neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL7 protein]]
neocuproine inhibits the reaction [ATP7A protein mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL1 protein]]; neocuproine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL1 protein]
[Copper binds to neocuproine] which affects the localization of CYCS protein; bathocuproine sulfonate inhibits the reaction [[Copper binds to neocuproine] which affects the localization of CYCS protein]
[neocuproine affects the abundance of Copper] inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; [neocuproine affects the abundance of Copper] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]
neocuproine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNG protein]; neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNG protein]]
[[Copper binds to neocuproine] which results in increased activity of MAPK3 protein] which results in increased phosphorylation of MBP protein; [Copper binds to neocuproine] which results in increased activity of MAPK3 protein
[[Copper binds to neocuproine] which results in increased activity of MAPK8 protein] which results in increased phosphorylation of JUN protein; [Copper binds to neocuproine] which results in increased activity of MAPK8 protein; bathocuproine sulfonate inhibits the reaction [[Copper binds to neocuproine] which results in increased activity of MAPK8 protein]
[neocuproine affects the abundance of Copper] inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; [neocuproine affects the abundance of Copper] inhibits the reaction [TNF protein results in increased expression of SELE protein]
[neocuproine affects the abundance of Copper] inhibits the reaction [TNF protein results in increased activity of SP1 protein]; [neocuproine affects the abundance of Copper] inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; [neocuproine affects the abundance of Copper] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; [neocuproine affects the abundance of Copper] inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; [neocuproine affects the abundance of Copper] inhibits the reaction [TNF protein results in increased expression of SELE protein]; [neocuproine affects the abundance of Copper] inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; [neocuproine affects the abundance of Copper] inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] neocuproine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]
neocuproine inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein]
[neocuproine affects the abundance of Copper] inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; [neocuproine affects the abundance of Copper] inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]
neocuproine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of VEGFA protein]; neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of VEGFA protein]]